PTC Therapeutics PTCT Change in fair value of contingent consideration
Change in fair value of contingent consideration at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's change in fair value of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's change in fair value of contingent consideration?
- PTC Therapeutics (PTCT) reported change in fair value of contingent consideration of -$800K in Q1 2025.
- How has PTC Therapeutics's change in fair value of contingent consideration changed year-over-year?
- PTC Therapeutics's change in fair value of contingent consideration decreased by 700.0% year-over-year, from -$100K to -$800K.
- What is the long-term trend for PTC Therapeutics's change in fair value of contingent consideration?
- Over 2 years (2021 to 2024), PTC Therapeutics's change in fair value of contingent consideration has grown at a 199.2% compound annual growth rate (CAGR), from -$500K to -$4.48M.
- What does change in fair value of contingent consideration mean?
- The non-cash adjustment to the fair value of liabilities related to potential future payments for business acquisitions. Fluctuations reflect changes in the probability or timing of achieving specific performance milestones.